Search Results
Dr. Weber on Selecting Immunotherapy for Patients With Melanoma
Dr. Weber on Discontinuing Immunotherapy in Melanoma
Dr. Weber on Risk and Benefits With Immunotherapy Combos in Melanoma
Dr. Weber on Adjuvant Pembrolizumab in Melanoma
Dr. Weber on Next Steps With Pembrolizumab as Melanoma Treatment
Dr. Hamid on Patient Selection for Immunotherapy Regimens in Melanoma
Dr. Weber on Future Treatment Approaches for Patients With Melanoma
Metastatic Melanoma: The Immunotherapy Approach
Dr. Weber on Adjuvant Approaches in Stage III Melanoma
Dr. Weber on Duration of Checkpoint Inhibitor Therapy in Melanoma
Dr. Jeffrey Weber on Potential Breakthrough "Cures" in Melanoma
Dr. Weber on the Toxicity Profile of Nivolumab Versus Ipilimumab for Melanoma
